Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
about
The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphomaCheckpoint inhibitors in hematological malignanciesPD-L1 Status in Refractory Lymphomas.PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.Multiparametric immune profiling in HPV- oral squamous cell cancerMechanisms of Immune Tolerance in Leukemia and Lymphoma.Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.Germline mutations predisposing to diffuse large B-cell lymphoma.The emerging role of immune checkpoint inhibition in malignant lymphoma.Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopChallenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.Targeting the programmed death-1 pathway in lymphoid neoplasms.Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies.Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T.Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers.Genetics of diffuse large B cell lymphoma.Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells.Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma.
P2860
Q33597192-F16E80B4-687E-48C3-84ED-555BC4453E3FQ33651495-5BE57659-613B-4AE5-8C2F-00254B536076Q36197517-936BD73A-D3EF-4521-8279-99572F7E5273Q37644975-45214624-F2E6-4A3E-AF0F-FA192C96108DQ38669131-AC5C83E7-1BAA-4A94-A67F-EC41E4260327Q38671420-A8E52D22-9292-4328-9814-32FA3A81F0FCQ38683034-5E209A1A-9196-42CB-B8DD-8F73F42213C5Q38739035-F8DF3C3E-44DA-48BD-8FFD-53FAF0196D2FQ38756189-4B1EFA8E-EDE6-4DB2-BFD1-1BA731872AAFQ38791036-0F6BB40E-E00E-462B-91D4-21329D28E8E3Q38821875-B04FD880-8AEF-4F88-A5AE-94F1D644382AQ39055861-F4247BFB-6E24-4822-ADEB-BC412033CEBAQ39153358-930D48FD-EAFD-43DC-92B8-FEC2A8D438A7Q39237785-956D96B2-AA97-4DA7-AD9B-589E800AEF3EQ39381251-4DB78AD4-E78C-4DDE-9A92-BB73EF122A44Q47093886-20DB2664-D6D7-41E5-B156-642313B4AC3FQ47424027-4F6B07B6-4D86-467B-A8FC-16691820FFDEQ48525241-2491169D-C17D-47D6-A97B-A41B356E5224Q49859661-FC7AA5A4-A137-495B-B207-054F81809207Q52582248-609B522D-072E-4CC0-9C4C-9A982070D86BQ52643503-A868482F-09DE-47E9-ABCE-348BB73F7158Q52653323-C5D8925C-EF38-4659-81FC-EC03562A99F1Q55003479-B007952A-07B5-4BCC-98B2-7481033599C9
P2860
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
@en
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
@nl
type
label
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
@en
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
@nl
prefLabel
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
@en
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
@nl
P2093
P50
P1433
P1476
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
@en
P2093
Christer Sundström
Gunilla Enblad
Huilai Zhang
Konstantinos Georgiou
Longyun Chen
Marco Fangazio
Mattias Berglund
P304
P356
10.1182/BLOOD-2015-12-686550
P407
P50
P577
2016-03-30T00:00:00Z